Comparison of unique clinical indicators of non-alcoholic fatty liver disease (NAFLD) in obese and non-obese (lean) patients.

被引：0
|
作者：
Modi, AA
Chuang, AZ
Zela, SA
Ankoma-Sey, V
机构：
[1] Univ Texas, Med Sch Houston, Houston, TX USA
[2] Liver Associates Texas, Houston, TX USA
来源：
HEPATOLOGY | 2004年 / 40卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：586A / 586A
页数：1
相关论文
共 50 条
  • [31] Letter: Helicobacter pylori in lean and obese patients with non-alcoholic fatty liver disease
    Kountouras, J.
    Polyzos, S. A.
    Katsinelos, P.
    Doulberis, M.
    Zavos, C.
    Kazakos, E.
    Boziki, M.
    Tzivras, D.
    Kotronis, G.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 46 (06) : 637 - 638
  • [32] Non-alcoholic fatty liver disease in non-obese individuals: the impact of metabolic health
    Eslam, Mohammed
    Fan, Jian-Gao
    Mendez-Sanchez, Nahum
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2020, 5 (08): : 713 - 715
  • [33] The frequency of non-alcoholic fatty liver disease in non-obese young medical professionals
    Aziz, Bilal
    Nazar, Tazeen
    Irfan, Muhammad
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2021, 71 (07) : 1878 - 1881
  • [34] A significant association of non-obese non-alcoholic fatty liver disease with sarcopenic obesity
    Kashiwagi, Kazuhiro
    Takayama, Michiyo
    Fukuhara, Kayoko
    Shimizu-Hirota, Ryoko
    Chu, Po-Sung
    Nakamoto, Nobuhiro
    Inoue, Nagamu
    Iwao, Yasushi
    Kanai, Takanori
    CLINICAL NUTRITION ESPEN, 2020, 38 : 86 - 93
  • [35] Non-alcoholic fatty liver disease in non-obese individuals: Prevalence, pathogenesis and treatment
    Molina-Molina, Emilio
    Krawczyk, Marcin
    Stachowska, Ewa
    Lammert, Frank
    Portincasa, Piero
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2019, 43 (06) : 638 - 645
  • [36] Lean or non-obese nonalcoholic fatty liver disease patients: Are they really lean?
    Han, Eugene
    Lee, Yong-ho
    CLINICAL AND MOLECULAR HEPATOLOGY, 2023, 29 (04) : 980 - 983
  • [37] Risk factors and metabolic abnormality of patients with non-alcoholic fatty liver disease: Either non-obese or obese Chinese population
    Shou-Wu Lee
    Teng-Yu Lee
    Sheng-Shun Yang
    Chun-Fang Tung
    Hong-Zen Yeh
    Chi-Sen Chang
    Hepatobiliary & Pancreatic Diseases International, 2018, 17 (01) : 45 - 48
  • [38] Risk factors and metabolic abnormality of patients with non-alcoholic fatty liver disease: Either non-obese or obese Chinese population
    Lee, Shou-Wu
    Lee, Teng-Yu
    Yang, Sheng-Shun
    Tung, Chun-Fang
    Yeh, Hong-Zen
    Chang, Chi-Sen
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2018, 17 (01) : 45 - 48
  • [39] Nutritional investigation of non-obese patients with non-alcoholic fatty liver disease: The significance of dietary cholesterol
    Yasutake, Kenichiro
    Nakamuta, Makoto
    Shima, Yuki
    Ohyama, Akiko
    Masuda, Kaori
    Haruta, Noriko
    Fujino, Tatsuya
    Aoyagi, Yoko
    Fukuizumi, Kunitaka
    Yoshimoto, Tsuyoshi
    Takemoto, Ryosuke
    Miyahara, Toshihiko
    Harada, Naohiko
    Hayata, Fukuko
    Nakashima, Manabu
    Enjoji, Munechika
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2009, 44 (04) : 471 - 477
  • [40] Non-obese or lean non-alcoholic fatty liver disease was associated with increased risk of cancer in patients with type 2 diabetes mellitus
    Chen, Ning
    Zhou, Jingqi
    Wang, Kai
    Li, Xiaoying
    Li, Zhibin
    BMJ OPEN DIABETES RESEARCH & CARE, 2023, 11 (01)
12345